A memo from the NIH's acting director indicated research and clinical studies that began prior to Trump's inauguration can ...
Acting NIH director Memoli clarifies communication restrictions as White House moves to freeze US government grants ...
Biotech startups generally rely on small business innovation grants to develop their technology. The Trump administration's ...
As the Trump administration issued an abrupt pause to federal financial assistance, the move threatened billions in grants ...
Pharmaron, a Chinese biotech firm, is currently using hundreds of thousands of taxpayer dollars to test pharmaceuticals on up ...
Just days after President Trump imposed broad restrictions on communications, meetings, travel and public appearances at the ...
The agency expects “additional guidance” this week on the communications freeze — which unleashed confusion about whether ...
Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...
"We need to know what adverse events are. We need to understand the safety of every drug, mifepristone, and every other drug.
The Trump Administration’s abrupt cancellation of National Institutes of Health meetings and grant reviews has sparked ...
The Scientific Management Review Board (SMRB) was recently re-established to advise the National Institutes of Health (NIH) ...